Pfizer reports quarterly Q1'23 revenues of US$18.3 Billion
Pfizer announces making deep cuts to Phase II clinical trial programs in cardiology and inflammatory dieseases.
https://www.biospace.com/article/releases/pfizer-reports-first-quarter-2023-results/?keywords=pfizer
https://www.biospace.com/article/pfizer-cuts-mid-stage-candidates-amid-declining-revenues/